The diagnosis of cancer elicits a broad range of well-characterized stress-related biobehavioral responses. Recent studies also suggest that an individual's neuroendocrine stress response can influence tumor biology. One of the major physiological pathways altered by the response to unrelenting social stressors is the hypothalamic-pituitary-adrenal or HPA axis. Initially following acute stress exposure, an increased glucocorticoid response is observed; eventually, chronic stress exposure can lead to a blunting of the normal diurnal cortisol pattern. Interestingly, recent evidence also links high primary tumor glucocorticoid receptor expression (and associated increased glucocorticoid-mediated gene expression) to more rapid estrogen-independent breast cancer progression. Furthermore, animal models of human breast cancer suggest that glucocorticoids inhibit tumor cell apoptosis. These findings provide a conceptual basis for understanding the molecular mechanisms underlying the influence of the individual's stress response, and specifically glucocorticoid action, on breast cancer and other solid tumor biology. How this increased glucocorticoid signaling might contribute to cancer progression is the subject of this review.
Introduction
The human biobehavioral response to stressors includes physiological changes that are initiated through an individual's interaction with the social environment. In response to these environmental stressors, including social stressors, well-defined physiological changes occur at the organismal level. These changes can be buffered by social support networks, thereby mitigating the deleterious effects of the stress response. However, when life's stressors are unrelenting and social support or other resources (e.g. financial resources) are insufficient, neuroendocrine pathways can become deregulated. It is this deregulation of physiological pathways that underlies the mechanisms whereby psychosocial stressors are hypothesized to influence the biology of chronic disease.
Cardiovascular and immune-related diseases have long served as examples of the stress response-disease relationship (Black and Garbutt, 2002; Stojanovich and Marisavljevich, 2008) . More recent studies have begun to explore connections between psychosocial factors and cancer biology. Indeed, recent clinical, epidemiological, and animal-based studies suggest there is a biobehavioral influence on tumor progression (Armaiz-Pena et al., 2009; Costanzo et al., 2011) . However, evidence for the impact of psychosocial factors on cancer initiation (rather than progression) has been less consistent (Costanzo et al., 2011) . Nevertheless, it is well-established that neuroendocrine hormones (e.g. glucocorticoids and noradrenaline) can and do influence cancer biology (Armaiz-Pena et al., 2009) . Thus, the fact that significant stress exposure can lead to deregulation of the neuroendocrine axis has led to further investigation into the effects of psychosocial factors on cancer biology as outlined below.
There are several neuroendocrine cell signaling mechanisms, executed downstream of both the adrenal and sympathetic systems, which could contribute to cancer growth. Recent reviews have outlined some neuroendocrine-cancer relationships and have extensively outlined neuroendocrine influences on the immune system (Armaiz-Pena et al., 2009; Costanzo et al., 2011) . The immune system has well-established and important roles in the progression of some cancer types (e.g. melanoma and renal cell carcinoma); however, its role in other cancers is less well understood. The overall impact of the immune system on cancer biology [reviewed in (Grivennikov et al., 2010) ] and specifically, the social stress-induced modulation of immunity are reviewed extensively elsewhere (Armaiz-Pena et al., 2009; Costanzo et al., 2011) .
This review instead focuses specifically on glucocorticoids (GCs), steroid hormones that are either secreted from the adrenal gland during exposure to acute and chronic stressors or administered pharmacologically to reduce inflammation, and the role of GC signaling in epithelial cancer biology. We discuss potential mechanisms through which endogenous GCs (cortisol in humans and corticosterone in rodents) may influence cancer progression. These data suggest that the routine pharmacological use of 0889-1591/$ -see front matter Ó 2012 Elsevier Inc. All rights reserved. http://dx.doi.org/10.1016/j.bbi.2012.10.022
